Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy - ScienceDirect
A PD 1 Inhibitor Fairy Tale - YouTube
Current Oncology | Free Full-Text | Immune Checkpoint Inhibitors in Cancer Therapy
Using combination therapy to overcome insufficient responses in programmed death ligand-1 (PD-1) inhibitors
Do Checkpoint Inhibitors Increase Rejection Risk? - Division of Nephrology
Revisiting the PD-1 pathway | Science Advances
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
PD-1/PD-L1 inhibitor 2(BMS-202)_ImmunoWay Biotechnology Company |抗体|病理抗体|诊断抗体
Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment | Journal for ImmunoTherapy of Cancer
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms - Annals of Oncology
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
PD-1 and PD-L1 inhibitors - Wikipedia
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Current issues and perspectives in PD-1 blockade cancer immunotherapy | SpringerLink
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Immune checkpoint blockade in HIV - eBioMedicine
Immune Checkpoint Inhibitors - NCI
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker - Wang - 2020 - Cancer Medicine - Wiley Online Library
